Bioanalytical scientist, Translational Biomarker and Bioanalysis
Ready to shape the future of treatments for neurodegenerative diseases? Join BioArctic, a well-funded, research-driven biotech in Stockholm with highly skilled and collaborative colleagues.
BioArctic is looking for a passionate Bioanalytical Scientist to join our dynamic and growing portfolio of projects, ranging from early discovery to phase II clinical development. In this highly innovative environment, you will work alongside skilled and dedicated colleagues in one or several project teams, contributing to the development of biological drugs targeting neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and ALS.
The role includes the following areas of responsibilities:
Active participation as project member and support the project(s) with reaching their overall goals.
Identifying, developing and qualifying quantitative bioanalytical methods such as immunoassays suitable for efficacy and pharmacokinetic read outs in preclinical in vivo studies as well as translation to clinical Phase I and II studies.
Planning, execution and delivery of experiments with high quality, within agreed timelines and according to project objectives.
Documentation and communication of results within specific projects and functions.
Minimum Requirements/Qualifications:
MSc or PhD in relevant natural science discipline, such as biomedicine, biochemistry, molecular biology, pharmacology or neuroscience.
Experience of developing and qualifying quantitative immunoassays on technology platforms such as ELISA, MSD and/or SIMOA for the use of diagnostics and/or pharmacodynamic and exposure analyses.
Proven track record of developing and qualifying highly sensitive quantitative assays, as well as experience applying these in various tissue matrices such as human plasma and CSF.
Experience of developing extraction and sample preparation protocols from various tissue matrices.
Good communication skills in English (oral, written, and presentation).
Further desirable experiences:
Experience of drug development and/or biomarker research in neurodegenerative disorders.
Experience of quantitative bioanalysis of antibody conjugates and other modalities such as oligonucleotides and small molecules
As a person, you are proactive, you take initiatives and take great responsibility for your own work in aiming to reach the project goals. You are a team player who enjoy sharing your ideas and experiences with colleagues and you have strong communication skills. You demonstrate and are inspired by the behaviors that reinforce BioArctic’s core values (Care, Challenge and Collaborate).
The vacancy is a 12-month temporary position, located at our headquarters in Stockholm. Deadline for application, January 22nd. Candidate selection are made on a continuous basis, and the advertisement may be closed before the deadline.
If you’re ready to make a real difference for patients with high unmet medical needs, apply today and join our mission.
For further information about BioArctic and our mission, please visit www.bioarctic.com.
This recruitment process is managed directly by BioArctic. We kindly decline contact from external recruitment agencies and vendors.
- Department
- Research & Development
- Role
- Research
- Locations
- Stockholm
About BioArctic
BioArctic, founded in 2003, is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. BioArctic has a broad project portfolio of selective antibodies against various diseases of the central nervous system. Several of the projects utilize the company's proprietary BrainTransporter™, which is a technology that has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic has around 150 employees, is headquartered in Stockholm and BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap.
Already working at BioArctic?
Let’s recruit together and find your next colleague.